Effect of albumin concentration and serum matrix on ischemia-modified albumin

Clin Biochem. 2010 Feb;43(3):345-8. doi: 10.1016/j.clinbiochem.2009.09.006. Epub 2009 Sep 19.

Abstract

Objectives: There is concern that ischemia-modified albumin (IMA) levels measured by albumin cobalt binding (ACB) assay reflect mainly albumin concentrations rather than myocardial ischemia.

Design and methods: Serum matrix and proteins were separated from a serum pool by a membrane filter. Two series of pools with albumin concentrations of 10, 20, 30, 40, 50, and 60 g/L were prepared either with human albumin or serum protein fraction. IMA values of these pools were measured in quintiplicate.

Results: There was a strong negative correlation between IMA and albumin levels in both pools. IMA change corresponding to each 10 g/L difference in albumin concentration was 37% and 48% in these pools.

Conclusions: ACB assay reflects albumin concentrations rather than IMA. Primary predictor of IMA in serum matrix is albumin concentration.

MeSH terms

  • Biological Assay / methods
  • Blood Proteins / chemistry
  • Blood Proteins / metabolism
  • Cobalt / metabolism
  • Humans
  • Myocardial Ischemia / blood*
  • Serum Albumin* / chemistry
  • Serum Albumin* / metabolism

Substances

  • Blood Proteins
  • Serum Albumin
  • Cobalt